Pacira BioSciences (PCRX) Insider Trading & Ownership $19.45 +0.47 (+2.48%) (As of 02:27 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Pacira BioSciences (NASDAQ:PCRX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.40%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$136,240.40Number OfInsiders Selling(Last 12 Months)6Amount OfInsider Selling(Last 12 Months)$3.42 M Get PCRX Insider Trade Alerts Want to know when executives and insiders are buying or selling Pacira BioSciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PCRX Insider Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Pacira BioSciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/13/2024Daryl GauglerCOOSell500$19.76$9,880.00 9/13/2024Daryl GauglerCOOSell500$12.86$6,430.00 8/16/2024Marcelo BigalDirectorBuy1,512$13.25$20,034.00 8/12/2024Frank D LeeCEOBuy8,264$12.10$99,994.40 8/12/2024Mark FroimsonDirectorBuy1,400$11.58$16,212.00 8/2/2024Jonathan SloninInsiderSell945$20.05$18,947.25 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 7/2/2024Jonathan SloninInsiderSell2,836$28.25$80,117.00 6/13/2024Daryl GauglerCOOSell1,000$28.38$28,380.00 6/13/2024Kristen WilliamsInsiderSell7,452$28.38$211,487.76 6/13/2024Paul J HastingsDirectorSell880$28.38$24,974.40 6/12/2024Lauren RikerSVPSell3,970$28.72$114,018.40 6/11/2024Jonathan SloninInsiderSell5,012$28.57$143,192.84 3/8/2024Gary W PaceDirectorSell90,000$30.60$2,754,000.00 3/6/2024Gary W PaceDirectorSell1,066$29.67$31,628.22 (Data available from 1/1/2013 forward) PCRX Insider Trading Activity - Frequently Asked Questions Who is on Pacira BioSciences's Insider Roster? The list of insiders at Pacira BioSciences includes Anthony Molloy, Charles A Reinhart III, Charles Anthony Laranjeira, Daryl Gaugler, David M Stack, Frank D Lee, Gary W Pace, John P Phd Longenecker, Jonathan Slonin, Kristen Marie Williams, Kristen Williams, Lauren Bullaro Riker, Lauren Riker, Marcelo Bigal, Mark A Kronenfeld, Mark Froimson, Max Reinhardt, Paul J Hastings, and Roy Winston. Learn more on insiders at PCRX. What percentage of Pacira BioSciences stock is owned by insiders? 6.40% of Pacira BioSciences stock is owned by insiders. Learn more on PCRX's insider holdings. Which Pacira BioSciences insiders have been buying company stock? The following insiders have purchased PCRX shares in the last 24 months: Frank D Lee ($99,994.40), Marcelo Bigal ($20,034.00), and Mark Froimson ($16,212.00). How much insider buying is happening at Pacira BioSciences? Insiders have purchased a total of 11,176 PCRX shares in the last 24 months for a total of $136,240.40 bought. Which Pacira BioSciences insiders have been selling company stock? The following insiders have sold PCRX shares in the last 24 months: Anthony Molloy ($20,917.26), Charles A Reinhart III ($48,191.64), Daryl Gaugler ($220,779.89), David M Stack ($197,211.42), Gary W Pace ($2,995,154.92), Jonathan Slonin ($242,257.09), Kristen Marie Williams ($239,473.01), Kristen Williams ($211,487.76), Lauren Bullaro Riker ($292,643.94), Lauren Riker ($114,018.40), Mark A Kronenfeld ($555,600.00), Paul J Hastings ($47,211.60), and Roy Winston ($87,117.13). How much insider selling is happening at Pacira BioSciences? Insiders have sold a total of 162,498 Pacira BioSciences shares in the last 24 months for a total of $5,272,064.06 sold. Pacira BioSciences Key ExecutivesMr. Charles A. Reinhart III (Age 63)C.P.A., M.B.A., Chief Financial Officer Compensation: $780.58kMr. Daryl Gaugler (Age 62)Chief Operating Officer Compensation: $778.77k2 recent tradesMs. Kristen Williams J.D. (Age 50)Chief Administrative Officer & Secretary Compensation: $799.63kMr. Anthony Molloy III (Age 50)Esq., Chief Legal & Compliance Officer Compensation: $581.41kMr. David M. Stack (Age 74)Advisor Compensation: $1.54MMr. Frank D. Lee (Age 56)CEO & Director 1 recent tradesMs. Lauren Bullaro Riker (Age 45)Principal Accounting Officer & Senior VP of Finance Compensation: $288.81kSusan MescoHead of Investor RelationsMr. Richard KahrVice President of Human ResourcesDr. Jonathan Slonin M.D. (Age 49)Chief Medical Officer Compensation: $815.25k More Insider Trading Tools from MarketBeat Related Companies Perrigo Insider Trading Supernus Pharmaceuticals Insider Trading Omeros Insider Trading Nektar Therapeutics Insider Trading Assembly Biosciences Insider Trading Cumberland Pharmaceuticals Insider Trading Eli Lilly and Company Insider Trading Johnson & Johnson Insider Trading AbbVie Insider Trading Merck & Co., Inc. Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:PCRX) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacira BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacira BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
